These findings indicated that LPS functioned as a tumor promotor in ESCC by inducing cancer cell stemness through LPS-TET3-HOXB2 signaling axis, which might provide a novel therapeutic strategy for ESCC. The gene discussed is HOXB2; the disease is cancer.